Riskpilot← Back to searchSign inGet full accessMEDWARE ApS
APSActiveCVR 32146910Sivlandvænget 27B, 1.Other software publishing · NACE 5829Est. 200910 employees
Revenue 2025
DKK 10,3M
+14% vs 2024
EBITDA margin
19.6%
+92% vs 2024
Equity ratio
86.4%
Financial strength
Net profit 2025
DKK 1,7M
+41% vs 2024
| Revenue | DKK 10,3M | +14% |
| EBITDA | DKK 2M | +92% |
| Net profit | DKK 1,7M | +41% |
| Total assets | DKK 8,5M | -17% |
| Equity | DKK 7,3M | -20% |
| Employees | 10 | — |
Legal name
MEDWARE ApS
CVR number
32146910
Legal form
Anpartsselskab
NACE code
5829 · Other software publishing
Founded
6. maj 2009
Share capital
DKK 125.000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er udvikling og salg af softwareprodukter.
Address
Sivlandvænget 27B, 1.
Phone
+4561274152
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 9.806 | 9.539 | 8.123 | 9.049 | 10.281 |
| Staff expenses | -6.157 | -6.312 | -6.938 | -8.001 | -8.268 |
| EBITDA | 3.649 | 3.226 | 1.185 | 1.048 | 2.013 |
| Depreciation & amort. | -37 | -35 | -8 | -0 | -0 |
| EBIT | 3.611 | 3.191 | 1.178 | 1.048 | 2.013 |
| Net financials | -19 | -323 | 316 | 513 | 192 |
| Profit before tax | 3.593 | 2.869 | 1.494 | 1.561 | 2.205 |
| Tax | 790 | 638 | 330 | 344 | 485 |
| Net profit | 2.802 | 2.231 | 1.164 | 1.217 | 1.721 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8.043 | 9.603 | 9.210 | 10.145 | 8.464 |
| Equity | 6.379 | 7.610 | 8.374 | 9.091 | 7.312 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.665 | 1.993 | 836 | 1.054 | 1.153 |
| Total debt | 1.665 | 1.993 | 836 | 1.054 | 1.153 |
EBITDA margin
19.6%
This company
15.8%
Market median
+24% vs market
20212025
Equity ratio
86.4%
This company
38.2%
Market median
+126% vs market
20212025
Return on equity
23.5%
This company
18.4%
Market median
+28% vs market
20212025
Net profit margin
16.7%
This company
8.1%
Market median
+106% vs market
20212025
Asset turnover
1.21×
This company
1.12×
Market median
+8% vs market
20212025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
UH Management | Management | 2009 |
JG Management | Management | 2009 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2015 | |
| Company | 50–66.65% | 50–66.65% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FAMILIEN HARDT SCHØNNEMANN HOLDING ApS
MEDWARE ApS Board members of MEDWARE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrik Hardt Schønnemann | Management | 0 companies |
| Jacob Glasdam | Management | 0 companies |